methylprednisolone acetate has been researched along with Kaposi Sarcoma in 1 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
Excerpt | Relevance | Reference |
---|---|---|
"Kaposi's sarcoma has been reported in patients receiving immunosuppressive therapy, most of whom are organ transplant recipients." | 1.29 | Kaposi's sarcoma with visceral involvement after intraarticular and epidural injections of corticosteroids. ( David, M; Hodak, E; Neeman, A; Sandbank, M; Trattner, A, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Trattner, A | 1 |
Hodak, E | 1 |
David, M | 1 |
Neeman, A | 1 |
Sandbank, M | 1 |
1 other study available for methylprednisolone acetate and Kaposi Sarcoma
Article | Year |
---|---|
Kaposi's sarcoma with visceral involvement after intraarticular and epidural injections of corticosteroids.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Glucocorticoids; Humans; Injection | 1993 |